Investor Links

Investor Contact

1-407-956-2250 EXT-9
info@avramedical.com

Investor Questions

About AVRA Medical Robotics

Creating intelligent medical robotic systems

AVRA Medical Robotics, Inc. ( OTC: AVMR ) is revolutionizing the practice of medicine by developing a fully autonomous surgical robotic system that “robotizes” a wide range of medical procedures currently being performed by human hands using surgical and non-surgical devices and instruments. AVRA is concentrating its research and development efforts to meet rising expectations of patients and practitioners alike for the precision, safety and speed offered by robotics and artificial intelligence when combined with proven medical devices and surgical instruments.

AVRA Press Releases

ORLANDO, FL – September 20, 2019 – AVRA Medical Robotics Appoints Two World Renowned Professionals to Chair its Medical and Scientific Advisory Boards

VIEW PRESS RELEASE >


ORLANDO, FL – August 28, 2019 – AVRA Medical Robotics Initiates Food and Drug Administration Approval Process

VIEW PRESS RELEASE >


NEWPORT BEACH, CA – July 24, 2019 – oVio Technologies Partners With AVRA Medical Robotics to Automate Procedures

VIEW PRESS RELEASE >


ORLANDO, FL – July 8, 2019 – AVRA Medical Robotics Announces its Participation in 10th Annual Meeting of the Society of Robotic Surgery

VIEW PRESS RELEASE >

AVRA Corporate Updates

On January 31, 2019 AVRA Medical Robotics’ CEO Mr. Barry Cohen released letter to update Shareholders

VIEW LETTER >


On July 31, 2017 the S1 was deemed effective by the SEC.

NOTICE OF EFFECTIVENESS >


On February 14, 2017, AVRA filed a Registration on Form S-1 with the U.S. Securities and Exchange Commission covering the resale of certain of our outstanding shares of common stock with a view to becoming a fully reporting public company.

VIEW OUR REGISTRATION STATEMENT >

To join our mailing list please submit your Name and Email below